每经AI快讯，华检医疗(01931.HK)公布，董事会建议将公司的英文名称由"IVD Medical Holding Limited"更改为"ETHK Labs Inc."，并将公司的中文双重外文名称由"华检医疗控股有限公司"更改为"华 检数字产业集团有限公司"。 （文章来源：每日经济新闻） ...

Core Viewpoint - The company proposes to change its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" to better reflect its new positioning as a key technology and infrastructure provider in the "ETHK" blockchain financial ecosystem [1] Group 1 - The board believes that the name change aligns with the overall best interests of the company and its shareholders [1] - The new name "ETHK Labs Inc./华检数字产业集团有限公司" aims to represent the company's ambition to become a global leader in digital industry innovation and core technology driving blockchain finance [1]

Core Viewpoint - The company proposes to change its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" to better reflect its strategic direction and focus on digital industries and blockchain financial ecosystems [1] Group 1 - The company aims to consolidate its existing business while actively exploring and positioning itself in cutting-edge fields such as digital industries and blockchain finance [1] - The name change is part of a broader strategy to establish a joint venture and deepen the global blockchain financial ecosystem under the "ETHK" core brand [1] - The board believes that the new name will better represent the company's ambition to become a key technology and infrastructure provider within the "ETHK" blockchain financial ecosystem [1]

Group 1 - The company has recently formed a partnership with ETHK Group to establish two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, which will become subsidiaries and their financial performance will be included in the group's consolidated financial statements [1] - ETHK Inc will focus on operating and developing the "ETHK" core brand, aiming to create a safe, efficient, compliant, and open decentralized financial platform through technological innovation and ecosystem integration [1] - ETHK HOLDINGS LIMITED will serve as a digital industry investment and acquisition hub, strategically integrating core assets, long-term institutional funding, and licensed financial institutions to create a self-sustaining growth model for the ETHK ecosystem [1] Group 2 - The board believes that the establishment of the joint venture aligns with the overall interests of the company and its shareholders, marking a significant step into the promising field of global on-chain finance [2] - The board expresses confidence in the future development prospects of the "ETHK" ecosystem as part of the company's innovation-driven development strategy [2]

Core Viewpoint - The company has entered into a partnership with ETHK Group to establish two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, which will be incorporated into the company's consolidated financial statements [1][2]. Group 1: Company Overview - ETHK Group is an investment holding group focused on the global blockchain financial ecosystem, aiming to build the next-generation blockchain financial kingdom named "ETHK" [1]. - ETHK Inc will focus on operating and developing the "ETHK" core brand, aiming to create a secure, efficient, compliant, and open decentralized financial platform [1]. - ETHK HOLDINGS LIMITED will serve as a central hub for digital industry investment and mergers, focusing on asset completion, capital activation, and compliance strengthening [2]. Group 2: Strategic Goals - The partnership aligns with the group's strategy to build a Real World Asset (RWA) platform technology ecosystem and explore blockchain finance [3]. - The initiative aims to expand from focusing on RWA transactions to a comprehensive blockchain financial ecosystem that includes technology infrastructure, asset categories, business models, and global compliance [3]. - The group aims to participate in and lead the process of "on-chain" integration of quality Chinese assets and efficient global asset circulation, creating a new long-term growth trajectory [3].

Core Viewpoint - The company has entered into a partnership with ETHK Group to establish two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, which will become subsidiaries and be included in the group's consolidated financial statements [1][2] Group 1: Company Overview - ETHK Inc will focus on operating and developing the "ETHK" core brand, aiming to create a safe, efficient, compliant, and open decentralized financial platform through technological innovation and ecosystem integration [1] - ETHK HOLDINGS LIMITED will serve as a digital industry investment and acquisition hub, strategically focusing on asset completion, capital activation, and compliance strengthening [1] Group 2: Strategic Goals - The strategy involves a three-pronged approach of "assets-capital-licenses" to identify and integrate key industry players with core assets, long-term funding institutions, and licensed financial entities globally [1] - The goal is to create a self-sustaining growth cycle that provides high-quality, scalable, and sustainable resource pools and value buffers for ETHK Inc and the entire ecosystem, thereby enhancing long-term competitive barriers and future value release potential [1] Group 3: Board Perspective - The board believes that the establishment of the joint venture aligns with the overall interests of the company and its shareholders, marking a significant step into the promising emerging field of global on-chain finance [2] - The board expresses confidence in the future development prospects of the "ETHK" ecosystem [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 建議更改公司名稱 董 事 會（「董事會」）建 議 將 本 公 司 之 英 文 名 稱 由「IVD Medical Holding Limited」更 改 為「ETHK Labs Inc.」，並 將 本 公 司 之 中 文 雙 重 外 文 名 稱 由「華 檢 醫 療 控 股 有 限 公 司」更 改 為「華 檢 數 字 產 業 集 團 有 限 公 司」（「建議更改公司名稱」）。建 議 更 改 公 司 名 稱 須 待 下 列 條 件 獲 達 成 後，方 可 作 實：(i)股 東 於 本 公 司 特 別 股 東 大 會（「特 別股東大會」）上 通 過 特 別 決 議 案 批 准 建 議 更 改 公 司 名 稱；及(ii)開曼群島公司 註 冊 處 處 長 批 准 建 議 更 改 公 司 名 稱。 建議更改公司名稱 華 檢 醫 療 控 股 有 限 公 司（「本 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 IVD Medical Holding Limited 華檢醫療控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1931） 透 過「ETHK」核 心 品 牌 深 化 全 球 鏈 上 金 融 生 態 戰 略 佈 局 本 公 告 乃 由 華 檢 醫 療 控 股 有 限 公 司（「本公司」或「華檢醫療」，連 同 其 附 屬 公 司 統 稱「本集團」）自 願 作 出，旨 在 向 股 東 及 潛 在 投 資 者 提 供 本 集 團 業 務 發 展 的 最 新 資 料。 本 公 司 董 事 會（「董事會」）欣 然 宣 佈，本 公 司 於 近 期 與ETHK Group（「合作方」）達 成 合 作，共 同 投 資 成 立 兩 家 新 公 司ETHK Inc及ETHK HOLDINGS LIMITED（「合 資 公 司」）。合 資 公 司 將 成 為 ...

IVD Medical Holding Limited 華檢醫療控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1931） 延遲寄發通函 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 茲 提 述 本 公 司 日 期 為 二 零 二 五 年 八 月 十 五 日 之 公 告（「該公告」），內 容 有 關 於 公開市場交易中潛在購買總值高達30億 港 元 之 加 密 貨 幣（「潛在加密貨幣購買」） 之 重 大 收 購 事 項。除 文 義 另 有 所 指 外，本 公 告 所 用 詞 彙 與 該 公 告 所 界 定 者 具 有 相 同 涵 義。 誠 如 該 公 告 所 披 露，載 有（其 中 包 括）購 買 授 權 及 潛 在 加 密 貨 幣 購 買 之 進 一 步 詳 情、股 東 特 別 大 會 通 告 及 上 市 規 則 規 定 之 其 他 資 料 之 通 函，預 期 將 於 二 零 二 ...

Core Viewpoint - The emergence of "on-chain healthcare" in the Hong Kong stock market is marked by significant investments in digital asset models, particularly through the tokenization of real-world assets (RWA) in the healthcare sector [1][5]. Group 1: Company Actions - Huajian Medical announced a plan to invest HKD 31.42 billion to acquire a 20.31% stake in Guofu Quantum, a financial technology platform, indicating a shift towards digital asset integration in healthcare [1][2]. - The company initiated a digital transformation in July 2024, aiming to tokenize ownership of 3,000 IVD testing devices and further develop an RWA exchange strategy [2]. - Other companies like Meinian Health and Hanyu Pharmaceutical are also exploring RWA models, with Hanyu's stock surging by 19.98% after announcing the tokenization of future revenue rights for its GLP-1 weight loss drug pipeline [3][5]. Group 2: Industry Trends - The RWA concept, which began in 2017, aims to enhance liquidity in traditional financial assets by digitizing them on the blockchain, with applications expanding to various asset classes [4]. - The healthcare industry faces common challenges such as financing difficulties due to long development cycles and high costs, making RWA tokenization an attractive solution to lower investment barriers and attract global capital [5][6]. Group 3: Market Reactions and Challenges - The rapid announcements from multiple healthcare companies have led to a fervent response in the capital markets, with significant stock price increases observed [3][5]. - However, there are concerns regarding the potential for speculative behavior, as some companies may be leveraging the trend without genuine innovation [6]. - Key challenges include regulatory compliance across different jurisdictions, accurate asset valuation, and ensuring liquidity in RWA projects, which are critical for their success [6][7][8].